7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Polycythemia Vera D011087 13 associated lipids
Mucocutaneous Lymph Node Syndrome D009080 9 associated lipids
Hyperalgesia D006930 42 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Cardiomyopathies D009202 10 associated lipids
Disease Susceptibility D004198 12 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Mogelvang R et al. Comparison of osteoprotegerin to traditional atherosclerotic risk factors and high-sensitivity C-reactive protein for diagnosis of atherosclerosis. 2012 Am. J. Cardiol. pmid:22100028
Chung E and Rylander MN Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors. 2012 Cell Stress Chaperones pmid:22116637
Koch FP et al. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. 2012 Clin Oral Investig pmid:20938793
Li J et al. Effect of oscillating fluid flow stimulation on osteocyte mRNA expression. 2012 J Biomech pmid:22119108
Ozkok A et al. Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. 2012 Clin J Am Soc Nephrol pmid:22490874
Funck-Brentano T et al. Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. 2012 PLoS ONE pmid:22432033
Bilgir O et al. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. 2012 Transfus. Apher. Sci. pmid:22079264
Rojano-Mejía D et al. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. 2012 Maturitas pmid:22079369
Ueland T et al. TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. 2012 Curr Heart Fail Rep pmid:22453763
Bogliolo L et al. Biomarkers and prognostic stratification in psoriatic arthritis. 2012 Reumatismo pmid:22690385
Olesen M et al. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. 2012 Mol. Cell. Endocrinol. pmid:22698523
Liang D et al. Zinc upregulates the expression of osteoprotegerin in mouse osteoblasts MC3T3-E1 through PKC/MAPK pathways. 2012 Biol Trace Elem Res pmid:22081405
García-Hernández A et al. High glucose concentrations alter the biomineralization process in human osteoblastic cells. 2012 Bone pmid:22086137
Kühn MC et al. Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. 2012 Mol. Cell. Endocrinol. pmid:22040599
Pineda B et al. Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. 2012 Menopause pmid:22067277
Chuang FH et al. Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions. 2012 J. Oral Pathol. Med. pmid:21793936
Rodriguez-Lorenzo LM et al. Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. 2012 J Tissue Eng Regen Med pmid:21800433
Duarte PM et al. Expression of immune-inflammatory markers in sites of chronic periodontitis in patients with type 2 diabetes. 2012 J. Periodontol. pmid:21859322
Røysland R et al. Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. 2012 Heart pmid:22373720
Brambila-Tapia AJ et al. MTHFR C677T, MTHFR A1298C, and OPG A163G polymorphisms in Mexican patients with rheumatoid arthritis and osteoporosis. 2012 Dis. Markers pmid:22377704
Gimenez-Maitre A et al. Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis. 2012 Eur. Respir. J. pmid:22379154
Mao X et al. Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. 2012 Inflammation pmid:22391745
Kim H et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. 2012 Arch. Gynecol. Obstet. pmid:22392486
Liu S et al. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. 2012 Hum. Cell pmid:22399266
Zhao NN et al. [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. 2012 Beijing Da Xue Xue Bao pmid:22353912
Zupan J et al. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. 2012 J. Biomed. Sci. pmid:22380539
Chai YC et al. Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. 2012 Biomaterials pmid:22381474
Hudson JB et al. Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. 2012 Calcif. Tissue Int. pmid:22382900
Singh DK et al. Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. 2012 Diabetes Res. Clin. Pract. pmid:22386825
Kanbe K et al. Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis. 2012 Rheumatol. Int. pmid:21789615
Nonaka CF et al. Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. 2012 Arch. Oral Biol. pmid:21871606
Zheleznyak A et al. Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. 2012 Mol Imaging Biol pmid:21853370
Dorota DK et al. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. 2012 Hypertens Pregnancy pmid:20822429
Chao TH et al. Opposite associations of osteoprotegerin and ZBTB40 polymorphisms with bone mineral density of the hip in postmenopausal Taiwanese women. 2012 J Chin Med Assoc pmid:22824048
Wang Y et al. Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model. 2012 Connect. Tissue Res. pmid:22827452
Zhou WJ et al. [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:22883830
Mayahara K et al. Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). 2012 Arch. Oral Biol. pmid:22884709
Hosbond SE et al. Osteoprotegerin as a marker of atherosclerosis: a systematic update. 2012 Scand. Cardiovasc. J. pmid:22506827
Li YF et al. The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. 2012 Osteoporos Int pmid:21892678
Ohe JY et al. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. 2012 Clin Oral Investig pmid:21938481
Tsubaki M et al. Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. 2012 Mol. Cell. Endocrinol. pmid:22579611
Wang YD et al. Dehydroepiandrosterone indirectly inhibits human osteoclastic resorption via activating osteoblastic viability by the MAPK pathway. 2012 Chin. Med. J. pmid:22613593
Ma Y et al. Effects of brucine on bone metabolism in multiple myeloma. 2012 Mol Med Rep pmid:22614932
Ma D et al. Smoke-induced signal molecules in bone marrow cells from altered low-density lipoprotein receptor-related protein 5 mice. 2012 J. Proteome Res. pmid:22616666
Kim EC et al. Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. 2012 J Endod pmid:22595110
da Silva RA et al. Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. 2012 J Endod pmid:22595116
Chen WH et al. Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. 2012 Chin J Integr Med pmid:22549392
Zheng D et al. The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. 2012 Bone pmid:22551876
Wang YD et al. Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. 2012 Horm. Metab. Res. pmid:22556124
Larussa T et al. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. 2012 World J. Gastroenterol. pmid:22529691
Niu YB et al. The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. 2012 Osteoporos Int pmid:22535190
Fichna M et al. Increased serum osteoprotegerin in patients with primary adrenal insufficiency receiving conventional hydrocortisone substitution. 2012 J. Physiol. Pharmacol. pmid:23388484
Torchinsky A et al. Bone loss in adult offspring induced by low-dose exposure to teratogens. 2012 J. Bone Miner. Metab. pmid:21960178
Hou JM et al. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22902986
Ma B et al. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22426695
Schweikle E et al. Osteoprotegerin positively regulates hematopoietic progenitor cells. 2012 Curr Stem Cell Res Ther pmid:22023625
García-Martín A et al. [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. 2012 Med Clin (Barc) pmid:22024564
Zijlstra WP et al. Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. 2012 J. Orthop. Res. pmid:22025323
Zhao N et al. Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. 2012 Orthod Craniofac Res pmid:22264323
Erkol A et al. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. 2012 Atherosclerosis pmid:22265272
Martin CK et al. Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. 2012 Oral Oncol. pmid:22265717
Reginster JY et al. Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. 2012 Bone pmid:22270053
Tibullo D et al. Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors. 2012 Hematol Oncol pmid:21544849
Leistner DM et al. Elevated levels of the mediator of catabolic bone remodeling RANKL in the bone marrow environment link chronic heart failure with osteoporosis. 2012 Circ Heart Fail pmid:22936827
Liu T et al. [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230665
Li L et al. [Progress of osteogenic effect of strontium and its application in orthopaedics]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230680
Qiu S et al. [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. 2012 Yao Xue Xue Bao pmid:22993856
Vik A et al. Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. 2012 Thromb. Res. pmid:22909822
Dong W et al. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:23268391
Feng Y et al. AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. 2012 Chin. Med. J. pmid:22964327
Pedersen S et al. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 2012 Cardiology pmid:22964478
Bargman R et al. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. 2012 Pediatr. Res. pmid:22926546
Cauley JA Commentary: A single biomarker in a complex metabolic pathway. 2012 Int J Epidemiol pmid:22933649
Delgado-Calle J et al. Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. 2012 Epigenetics pmid:22207352
Bao L et al. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model. 2012 Joint Bone Spine pmid:22154615
Shahnazari M et al. Bone turnover markers in peripheral blood and marrow plasma reflect trabecular bone loss but not endocortical expansion in aging mice. 2012 Bone pmid:22154841
Zheng CM et al. Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. 2012 Tohoku J. Exp. Med. pmid:22156488
Said F et al. The effect of etidronate on the periodontium of ovariectomized rats. 2012 J. Periodontol. pmid:22166164
Guo D et al. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. 2012 Mol. Cell. Biochem. pmid:22167620
Svensson M et al. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. 2012 Nephrol. Dial. Transplant. pmid:22172725
Kraus D et al. Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. 2012 Clin Oral Investig pmid:22186940
Zhao N et al. Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22196183
Chen J et al. OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. 2012 Rheumatol. Int. pmid:22210270
Giannopoulou C et al. Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. 2012 Acta Odontol. Scand. pmid:22214279
Bloch SL and Sørensen MS Otosclerosis: a perilabyrinthine threshold phenomenon. 2012 Acta Otolaryngol. pmid:22217131
Upton AR et al. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. 2012 Rheumatol. Int. pmid:21259010
Oue E et al. CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. 2012 Biochem. Biophys. Res. Commun. pmid:22771802
Bilgin E et al. Markers of bone metastases in breast and lung cancers. 2012 Asian Pac. J. Cancer Prev. pmid:23167338
Luo ZR and Xie QJ [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. 2012 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:23168201
Cui L et al. Effect of fluid flow-induced shear stress on osteoclast formation induced by osteocyte. 2012 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:22776650
Li YL and Wang H [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. 2012 Zhongguo Dang Dai Er Ke Za Zhi pmid:22989431
Tyagi AM et al. Formononetin reverses established osteopenia in adult ovariectomized rats. 2012 Menopause pmid:22781783
Kim IS et al. Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. 2012 J. Dent. Res. pmid:23086742
Xu Y et al. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803436
Zhu XF et al. [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803437
Nyrnes A et al. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. 2012 Gend Med pmid:23046763
Davenport C et al. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. 2012 Eur. J. Clin. Invest. pmid:22803952
Mirzaei K et al. Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. 2012 Minerva Med. pmid:22805623
Kleyer A et al. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. 2012 J. Bone Miner. Res. pmid:22806960
Belibasakis GN and Bostanci N The RANKL-OPG system in clinical periodontology. 2012 J. Clin. Periodontol. pmid:22092994

Table of Content